We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

27 hedge funds and large institutions have $12.9M invested in Tenax Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

175% more capital inflows, than outflows

Capital inflows: $2.05M | Capital outflows: $744K

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

8% more funds holding

Funds holding: 25 → 27 (+2)

3.26% more ownership

Funds ownership: 50.54% → 53.8% (+3.3%)

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.2M
2
ADAR1 Capital Management
ADAR1 Capital Management
Texas
+$502K
3
Morgan Stanley
Morgan Stanley
New York
+$329K
4
Raymond James Financial
Raymond James Financial
Florida
+$8.69K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$6.11K

Top Sellers

Rank Fund Capital Flow
1
VR Adviser
VR Adviser
New York
-$634K
2
Citadel Advisors
Citadel Advisors
Florida
-$74K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$19.2K
4
UBS Group
UBS Group
Switzerland
-$16.6K
5
BFCFSI
BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.
Iowa
-$7

TENX Hedge Fund Activity: Q2 2025 in Review

27 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2025, worth a combined $12.9M — down 1.4% from $13.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TENX positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.2M. The largest seller was VR Adviser, cutting an estimated $634K.

  • 27 institutional investors held Tenax Therapeutics (TENX) as of Q2 2025, up from 25 in Q1 2025.
  • Funds reported $12.9M of Tenax Therapeutics stock for Q2 2025, down 1.4% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q2 2025 and 1 closed out, a net change of +2 holders.
  • The largest Tenax Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $1.2M added.
  • The largest Tenax Therapeutics seller in Q2 2025 was VR Adviser, an estimated $634K sold.

Based on aggregated 13F filings for Q2 2025.